Exenatide twice daily versus premixed insulin aspart 70/30 in metformin-treated patients with type 2 diabetes: a randomized 26-week study on glycemic control and hypoglycemia (Q42613301)

From Wikidata
Jump to navigation Jump to search
scientific article published on February 2011
edit
Language Label Description Also known as
English
Exenatide twice daily versus premixed insulin aspart 70/30 in metformin-treated patients with type 2 diabetes: a randomized 26-week study on glycemic control and hypoglycemia
scientific article published on February 2011

    Statements

    Exenatide twice daily versus premixed insulin aspart 70/30 in metformin-treated patients with type 2 diabetes: a randomized 26-week study on glycemic control and hypoglycemia (English)
    1 reference
    Baptist Gallwitz
    1 reference
    Michael Böhmer
    1 reference
    Thomas Segiet
    1 reference
    Andrea Mölle
    1 reference
    Karsten Milek
    1 reference
    Bernd Becker
    1 reference
    Karin Helsberg
    1 reference
    Helmut Petto
    1 reference
    Natalie Peters
    1 reference
    Oliver Bachmann
    1 reference
    1 February 2011
    1 reference
    34
    1 reference
    604-606
    1 reference

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit